Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05686343

Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks

Conditions: Patent Ductus Arteriosus After Premature Birth

Sex: All
Ages: 1 Minute – 7 Days
Enrollment: 70
Sponsor: Ankara University

Location: Turkey

Summary

To define the characteristics of hemodynamically significant PDA by echocardiography, to investigate the systemic effects of the ductus with cerebral and renal Doppler flow studies, and to determine the oxygen consumption in the cerebral tissue with NIRS in newborns below 32 weeks of age with PDA.

Eligibility Criteria

Inclusion Criteria:Born at less than 32 weeks newbornsExclusion Criteria:Congenital heart diseaseSyndromic and/or major congenital anomaly

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05686343). StuddyBuddy aggregates publicly available trial information.